Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Osvaldo Rivera-Gonzalez"'
Publikováno v:
American journal of physiology. Endocrinology and metabolism.
Endothelin-1 (ET-1) is elevated in patients with systemic lupus erythematosus (SLE), an autoimmune disease characterized by high rates of hypertension, renal injury, and cardiovascular disease. SLE is also associated with increased prevalence of obes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::175d7f7f083beaa6ca726341bb0bc600
https://pubmed.ncbi.nlm.nih.gov/36476039
https://pubmed.ncbi.nlm.nih.gov/36476039
Autor:
Jürgen Wess, Antwi-Boasiako Oteng, Osvaldo Rivera-Gonzalez, Eugenia V. Gurevich, Vsevolod V. Gurevich
Publikováno v:
Pharmacological Reviews. :PHARMREV-AR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7ccd5255189d433dfeb3f243cdac3c9
https://doi.org/10.1124/pharmrev.121.000302
https://doi.org/10.1124/pharmrev.121.000302
Publikováno v:
Hypertension. 78
Endothelin-1 has been implicated in obesity related insulin resistance. Our lab recently demonstrated that ET-1 is elevated in adipose tissue of obese mice, and blockade of ET-1 receptors improves insulin sensitivity in a mouse model of diet induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1d2f3dfdd6bc5cb034fc47f406f8a66
https://doi.org/10.1161/hyp.78.suppl_1.p158
https://doi.org/10.1161/hyp.78.suppl_1.p158
Publikováno v:
Clin Sci (Lond)
Endothelin-1 (ET-1) is elevated in patients with obesity; however, its contribution to the pathophysiology related to obesity is not fully understood. We hypothesized that high ET-1 levels cause dyslipidemia, inflammation, and insulin resistance with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae86f526bcd48d594e7cbb43f1dbfe7b
https://europepmc.org/articles/PMC8650556/
https://europepmc.org/articles/PMC8650556/
Publikováno v:
The FASEB Journal. 35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e31f8aa9b6d16549422ea404b4e8331b
https://doi.org/10.1096/fasebj.2021.35.s1.02854
https://doi.org/10.1096/fasebj.2021.35.s1.02854
Publikováno v:
Obes Rev
The association between plasma endothelin-1 (ET-1) and obesity has been documented for decades, yet the contribution of ET-1 to risk factors associated with obesity are not fully understood. In 1994, one of first papers to document this association a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c583fb8b91b9aaa89860ad4549af6d
https://doi.org/10.1111/obr.13086
https://doi.org/10.1111/obr.13086
Publikováno v:
Journal of the Endocrine Society
Obesity is associated with increased levels of Endothelin-1 (ET-1). Blockade of ET-1 type A receptors (ETA) improves lipid profile in patients with chronic kidney disease; however the mechanism is unknown.[1] In adipocytes ETA activation increases li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20412cb8df901a98f0c7b3af1df54827
http://europepmc.org/articles/PMC7209660
http://europepmc.org/articles/PMC7209660
Autor:
Malgorzata Kasztan, Osvaldo Rivera-Gonzalez, Joshua S. Speed, Jermaine G. Johnston, Kelly A. Hyndman
Publikováno v:
Can J Physiol Pharmacol
High salt intake (HS) is associated with obesity and insulin resistance. ET-1, a peptide released in response to HS, inhibits the actions of insulin on cultured adipocytes through ET-1 type B (ETB) receptors; however, the in vivo implications of ETB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70aaa607fa9ca05cd58e4737ab58fe66
https://pubmed.ncbi.nlm.nih.gov/32083942
https://pubmed.ncbi.nlm.nih.gov/32083942
Publikováno v:
Journal of the Endocrine Society
Endothelin-1 (ET-1) is elevated in patients with obesity; however, its contribution to the pathophysiology related to obesity is not fully understood. Obesity is associated with dyslipidemia and insulin resistance, which may in part be mediated by in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::588dc6304c482993b0f128b68ac80250
http://europepmc.org/articles/PMC8265694
http://europepmc.org/articles/PMC8265694
Publikováno v:
The FASEB Journal. 34:1-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89634187bef7a11d8403ea63e0ffcd7a
https://doi.org/10.1096/fasebj.2020.34.s1.05432
https://doi.org/10.1096/fasebj.2020.34.s1.05432